🕵️ Aspira Women'S Health Inc. ($AWHL)
SEC insider & ownership activity, last 12 months · CIK 926617 · every row links its SEC filing
Over the last 12 months insiders bought $632K with no open-market selling against it. Jack W. Schuler bought $600K (Sep–Jun). Jack W. Schuler trimmed 9.1% → 8.7%; JACK W. Schuler Living Trust trimmed 9.1% → 8.6%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
3 buyers, $632K (8 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Jack W. Schuler | 4 | $600K | 0 | – | Jun 5, 2026 |
| Jeffrey K. Cohen | 2 | $25K | 0 | – | Sep 17, 2025 |
| John D. Fraser | 2 | $7K | 0 | – | Sep 17, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Jack W. Schuler | 8.7% | 13D | Jun 5, 2026 | filing ↗ | |
| JACK W. Schuler Living Trust | 8.6% | 13D | Jun 5, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jul 6, 2026 | filing ↗ |
| New financial obligation (2.03) | Jul 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 6, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 17, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 17, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 17, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 5, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jun 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 5, 2026 | filing ↗ |
| Material agreement (1.01) | May 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 20, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 26, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 30, 2026 | filing ↗ |
| New financial obligation (2.03) | Jan 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 29, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 29, 2025 | filing ↗ |
| Material agreement (1.01) | Dec 23, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Dec 23, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 23, 2025 | filing ↗ |
| Material agreement (1.01) | Dec 23, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 23, 2025 | filing ↗ |
| Material agreement (1.01) | Dec 16, 2025 | filing ↗ |
| Earnings (2.02) | Nov 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 14, 2025 | filing ↗ |
| Other events (8.01) | Oct 14, 2025 | filing ↗ |
| Material agreement (1.01) | Sep 19, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Sep 19, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 19, 2025 | filing ↗ |